取得演示
Now livetag icon
The official Gen AI Landscape report for 2026 is here. Don’t miss out!Get your copybanner icon
ERGOMED

7月 2026

7月 2026ERGOMED的市場佔有率分析

Partner with Ergomed for strategic study start-up services. Expedite your clinical trial with our early planning, global coverage, and data-driven insights.
行業: N/A
成立年份1997
僱員1001 - 5000
年度營收--
ergomedcro.com
ERGOMED
ERGOMED(包含公司地區)
  • ergomedcro.com
    ergomedcro.com
查看更多網站流量與參與度資訊

ERGOMED的熱門網域總造訪量

了解ERGOMED市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

ERGOMED的熱門網域平均造訪時長

分析ERGOMED參與度指標。

過去 3 個月平均造訪時長

子公司細目

ERGOMED的熱門網域平均頁面瀏覽量

了解ERGOMED如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

想要取得更深入的流量洞見?

篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。


ERGOMED按網域劃分的熱門競爭對手

看起來這裡的數據不足

無可顯示數據

標竿分析您的數位績效

辨識高價值機會,追蹤績效並贏得市場。


使用的熱門技術ERGOMED

这些是ERGOMED顶级域名使用的行业网站技术

付費廣告 (4)

DoubleClick

DoubleClick

轉換與分析 (3)

Google Analytics

Google Analytics

市場行銷 (3)

Google Marketing Platform

Google Marketing Platform

小工具 (3)

更多技術

8

檢視所有

準備好開發優質潛在客戶了嗎?

借助 SimilarWeb 銷售情報解決方案,了解網站能使用哪些技術來完善銷售宣傳手法,並縮短銷售週期。


新聞與訊號來自ERGOMED

透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。

新聞Permira acquired Ergomed plc for $859M on Sep 1st '23.Permira has completed the take private of Ergomed, a service provider to the pharmaceutical industry, for £703.1 million ($863.8 million; €807.1 million).
新聞Deb Kientop leaves Ergomed plc as Senior Vice President, Oncology Strategy and Innovation.Deb Kientop comes to Deka from ErgoMed, where she served as the Senior Vice President, Oncology Strategy and Innovation.
新聞Trialbee AB partners with Ergomed plc.Trialbee, the leader in technology-based patient matching and enrollment, has partnered with global clinical research organization ERGOMED plc (LSE: ERGO) to be the patient recruitment platform for their newly launched Rare Disease Innovation Center, partnering with their own novel Site Advantage™ solution for the better recruitment of rare disease patients.

查看所有ERGOMED信號

讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。